Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Pfreundschuh.2008b
%A Pfreundschuh, Michael
%A Ho, Anthony D.
%A Cavallin-Stahl, Eva
%A Wolf, Max
%A Pettengell, Ruth
%A Vasova, Ingrid
%A Belch, Andrew
%A Walewski, Jan
%A Zinzani, Pier-Luigi
%A Mingrone, Walter
%A Kvaloy, Stein
%A Shpilberg, Ofer
%A Jaeger, Ulrich
%A Hansen, Mads
%A Corrado, Claudia
%A Scheliga, Adriana
%A Loeffler, Markus
%A Kuhnt, Evelyn
%D 2008
%J The Lancet Oncology
%K IMISE-Publikationen
%N 5
%P 435–444
%T Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
%V 9
@article{Pfreundschuh.2008b,
added-at = {2014-10-15T15:04:15.000+0200},
author = {Pfreundschuh, Michael and Ho, Anthony D. and Cavallin-Stahl, Eva and Wolf, Max and Pettengell, Ruth and Vasova, Ingrid and Belch, Andrew and Walewski, Jan and Zinzani, Pier-Luigi and Mingrone, Walter and Kvaloy, Stein and Shpilberg, Ofer and Jaeger, Ulrich and Hansen, Mads and Corrado, Claudia and Scheliga, Adriana and Loeffler, Markus and Kuhnt, Evelyn},
biburl = {https://www.bibsonomy.org/bibtex/275898dc73eb805bd34987cad5847fe07/drtester},
interhash = {2874ae4d1f760fda9b94f2eb01e15c9c},
intrahash = {75898dc73eb805bd34987cad5847fe07},
journal = {The Lancet Oncology},
keywords = {IMISE-Publikationen},
number = 5,
pages = {435–444},
timestamp = {2014-10-15T15:04:15.000+0200},
title = {Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study},
volume = 9,
year = 2008
}